Zucara Therapeutics Inc.

📍 Vancouver, Canada🗓 Founded 2015👥 12 employees💰 Last funded May 2020
Biotechnology Research🌐 zucara.ca
Website LinkedIn
Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes. Our first-in-class therapeutic is focused on improving glucagon counterregulation by inhibiting somatostatin which is dysregulated in Type 1 diabetes. Preventing hypoglycemia will dramatically change diabetes disease management, improving both patient health and quality of life..
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Canada
1
Frequently asked questions
Who invested in Zucara Therapeutics Inc.?
Zucara Therapeutics Inc. has 2 investors on record on gritt.io, 2 mid-stage.
When did Zucara Therapeutics Inc. last raise funding?
The most recent investment in Zucara Therapeutics Inc. recorded on gritt.io was in May 2020.
When was Zucara Therapeutics Inc. founded?
Zucara Therapeutics Inc. was founded in 2015.
What industry is Zucara Therapeutics Inc. in?
Zucara Therapeutics Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Zucara Therapeutics Inc. based?
Zucara Therapeutics Inc. is headquartered in Vancouver, Canada.